Paolo Casali specialises in sarcoma, a rare’ cancer with at least 50 subgroups.Good practice, he believes, starts with a deep knowledge of the disease in front of you. This, in turn, requires a rigorous approach to clinical methodology something he feels the cancer community should pay more attention to, for the benefit of both patient care and clinical research.
